Gene · 11338
Papers2,147
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,147
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hotspots of Somatic Genetic Variation in Pituitary Neuroendocrine Tumors. | Cancers (Basel) | 2023 | 38067388 | PubTator, text mining | PubMed |
| Using the structural diversity of RNA: protein interfaces to selectively target RNA with small molecules in cells: methods and perspectives. | Front Mol Biosci | 2023 | 38033386 | PubTator, text mining | PubMed |
| CircHIPK3 relieves vascular calcification via mediating SIRT1/PGC-1α/MFN2 pathway by interacting with FUS. | BMC Cardiovasc Disord | 2023 | 38012555 | PubTator, text mining | PubMed |
| LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex. | Cell Death Dis | 2023 | 38007473 | PubTator, text mining | PubMed |
| A Multi-Omics Approach Revealed Common Dysregulated Pathways in Type One and Type Two Endometrial Cancers. | Int J Mol Sci | 2023 | 38003247 | PubTator, text mining | PubMed |
| Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective. | Cancer Cell Int | 2023 | 37993909 | PubTator, text mining | PubMed |
| A dual role of RBM42 in modulating splicing and translation of CDKN1A/p21 during DNA damage response. | Nat Commun | 2023 | 37993446 | PubTator, text mining | PubMed |
| Characterization of the SF3B1-SUGP1 interface reveals how numerous cancer mutations cause mRNA missplicing. | Genes Dev | 2023 | 37977822 | PubTator, text mining | PubMed |
| Changes in ADAR RNA editing patterns in CMV and ZIKV congenital infections. | BMC Genomics | 2023 | 37968596 | PubTator, text mining | PubMed |
| Assessing the Binding Mode of a Splicing Modulator Stimulating Pre-mRNA Binding to the Plastic U2AF2 Splicing Factor. | J Chem Inf Model | 2023 | 37967032 | PubTator, text mining | PubMed |
| RNA Editing in Cancer Progression. | Cancers (Basel) | 2023 | 37958449 | PubTator, text mining | PubMed |
| Variations of intronic branchpoint motif: identification and functional implications in splicing and disease. | Commun Biol | 2023 | 37949953 | PubTator, text mining | PubMed |
| Abnormal expression of PRKAG2-AS results in dysfunction of cardiomyocytes through regulating PRKAG2 transcription by interacting with PPARG. | Clin Epigenetics | 2023 | 37932845 | PubTator, text mining | PubMed |
| Genome-wide detection of human intronic AG-gain variants located between splicing branchpoints and canonical splice acceptor sites. | Proc Natl Acad Sci U S A | 2023 | 37931111 | PubTator, text mining | PubMed |
| PRMT5 and CDK4/6 inhibition result in distinctive patterns of alternative splicing in melanoma. | PLoS One | 2023 | 37917641 | PubTator, text mining | PubMed |
| Indacaterol inhibits collective cell migration and IGDQ-mediated single cell migration in metastatic breast cancer MDA-MB-231 cells. | Cell Commun Signal | 2023 | 37904233 | PubTator, text mining | PubMed |
| Research Progress on the Structural and Functional Roles of hnRNPs in Muscle Development. | Biomolecules | 2023 | 37892116 | PubTator, text mining | PubMed |
| RNA modification in cardiovascular disease: implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37884527 | PubTator, text mining | PubMed |
| Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential. | J Exp Clin Cancer Res | 2023 | 37880792 | PubTator, text mining | PubMed |
| The role of alternative pre-mRNA splicing in cancer progression. | Cancer Cell Int | 2023 | 37875914 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11338/papers?page=7